SCHEMBL1075241

SCHEMBL1075241

N=C(N)c1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4527805 0.76
SCHEMBL343264 0.76
SCHEMBL14764552 0.76
SCHEMBL17832467 0.76
Hydrochloric Acid SCHEMBL1049688 0.74 TSHR (0.39)
Hydrochloric Acid SCHEMBL1382983 0.74
SCHEMBL27537687 0.74
SCHEMBL16581185 0.73
SCHEMBL1374801 0.71
SCHEMBL5752399 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110263610-A1 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2011-10-27 US claimed
EP-2274302-A2 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2011-01-19 EP claimed
WO-2009123948-A2 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2009-10-08 WO claimed
CN-107406422-A Pyrazole derivatives as sGC stimulants 铁木医药有限公司 2017-11-28 CN disclosed
CN-105061313-B Androgen receptor modulating compounds 奥赖恩公司 2017-07-18 CN disclosed
EP-3028707-A1 METHODS FOR TREATING OR PREVENTING OPHTHALMOLOGICAL DISEASES Ophthotech Corporation (US) 2016-06-08 EP disclosed
US-20110263610-A1 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2011-10-27 US disclosed
EP-2274302-A2 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2011-01-19 EP disclosed
WO-2009123948-A2 COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS IRM LLC (BM) 2009-10-08 WO disclosed